BioNexus Gene Lab Corp. Agrees to Invest RM 1.2 million in Ascension Innovation to Advance Digital Health Innovation through AI adoption in Healthcare FOR IMMEDIATE RELEASE .
KUALA LUMPUR, Malaysia, April 19, 2024 BioNexus Gene Lab Corporation , a global leader in genomic diagnostics and healthcare technology, announces a strategic investment by its wholly owned.
EMS provider NEOTech is launching a New Product Introduction (NPI) and electronics manufacturing center of excellence at its Fremont, California facility.
NEOTech, a leading provider of electronic manufacturing services (EMS), design engineering, and supply chain solutions in the high-tech industrial, medical device, and aerospace/defense markets, is excited to announce the upcoming launch of a state-of-the-art New Product Introduction (NPI) and electronics manufacturing center of excellence at its Fremont, CA facility. Scheduled to commence operations in early April 2024, this facility represents a significant investment in expanding NEOTech’s capabilities and offerings to Fortune 500 clients seeking high-technology product manufacturing solutions.